Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Can biomarkers of coagulation, platelet activation, and inflammation predict mortality in patients with hematological malignancies?
Authors
Keywords
-
Journal
Hematology
Volume 23, Issue 2, Pages 89-95
Publisher
Informa UK Limited
Online
2017-08-21
DOI
10.1080/10245332.2017.1365458
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis
- (2016) E. Kastritis et al. BLOOD
- Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia
- (2016) Martin D. Berger et al. HEMATOLOGICAL ONCOLOGY
- Clinical and Prognostic Significance of Coagulation Assays in Pancreatic Cancer Patients With Absence of Venous Thromboembolism
- (2015) Wei Sun et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma
- (2015) Milla Elvi Linnea Kuusisto et al. ANNALS OF HEMATOLOGY
- Occupational exposure and sinonasal cancer: a systematic review and meta-analysis
- (2015) Alessandra Binazzi et al. BMC CANCER
- High coagulation factor VIII and von Willebrand factor in patients with lymphoma and leukemia
- (2015) Martin Mohren et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Inhibition of P-Selectin and PSGL-1 Using Humanized Monoclonal Antibodies Increases the Sensitivity of Multiple Myeloma Cells to Bortezomib
- (2015) Barbara Muz et al. Biomed Research International
- Fibrinogen and factor XIII at the intersection of coagulation, fibrinolysis and inflammation
- (2014) Berthold Hoppe THROMBOSIS AND HAEMOSTASIS
- Cytokine profiles in acute myeloid leukemia patients at diagnosis: Survival is inversely correlated with IL-6 and directly correlated with IL-10 levels
- (2013) Beatriz Sanchez-Correa et al. CYTOKINE
- Impact of Interleukin-6 in Hematological Malignancies
- (2013) Renate Burger TRANSFUSION MEDICINE AND HEMOTHERAPY
- Prognostic Significance of Antithrombin III Levels for Outcomes in Patients with Hepatocellular Carcinoma After Curative Hepatectomy
- (2012) Hiroshi Iwako et al. ANNALS OF SURGICAL ONCOLOGY
- Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia
- (2012) B. Hivert et al. BLOOD
- High D-dimer levels are associated with poor prognosis in cancer patients
- (2012) C. Ay et al. HAEMATOLOGICA
- IL-6/IL-6 receptor system and its role in physiological and pathological conditions
- (2011) Masahiko Mihara et al. CLINICAL SCIENCE
- Epidemiology, risk and outcomes of venous thromboembolism in cancer
- (2011) A. Falanga et al. Hamostaseologie
- Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma
- (2009) Jeong Eun Kim et al. ANNALS OF HEMATOLOGY
- The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes
- (2008) Apostolia Maria Tsimberidou et al. CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now